Overview
HBAR vs Injective is one of the most watched crypto matchups. Beyond headline prices, this comparison blends market structure, technical readings and probabilistic context without promising outcomes.
Quick winners
Full comparison
| Metric | HBAR | INJ |
|---|---|---|
| Price | $0.070020 | $5.10 |
| Market Cap | $3.06B | $490.41M |
| FDV | — | — |
| Volume 24h | $3.22M | $2.58M |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 29.00 | 99.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +3.64% | +5.97% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | HBAR | INJ |
|---|---|---|
| 1H | — | — |
| 24H | +1.02% | +3.59% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | HBAR | INJ |
|---|---|---|
| RSI | 49.02 | 49.29 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 67.35 | 0.29 |
| ADX | 21.33 | 12.19 |
| Support | 1,827.82 | 4.91 |
| Resistance | 1,960.30 | 5.47 |
| Trend | bearish | neutral |
| Momentum | 59.00 | — |
| Signal | neutral | neutral |
Automatic technical analysis
Indicator stacks for HBAR/INJ currently lean on separate regimes: bearish versus neutral. Treat MACD and RSI as context, not as standalone entry triggers.
Fundamentals
| Metric | HBAR | INJ |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | — | 0.00 |
| Github activity | — | 118.00 |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
HBAR
Injective
Pros and cons
Pros of HBAR
- Higher ranking for HBAR can translate into tighter spreads on major venues.
- HBAR often anchors narratives that attract sustained media and analyst coverage.
Cons of HBAR
- When dominance narratives fade, HBAR can lag hotter rotation names.
- Crowded positioning around HBAR sometimes amplifies squeeze or flush risk.
- Large-cap status for HBAR can mean slower percentage upside versus high-beta alternatives.
Pros of Injective
- Active volume bursts on INJ sometimes precede sharper tactical moves.
- Narrative optionality around Injective can reprice quickly when catalysts appear.
- Injective can offer higher relative beta when market attention rotates toward its niche.
Cons of Injective
- Smaller book depth versus large caps can increase slippage for Injective.
- Relative underperformance versus HBAR can persist through entire market regimes.
Which looks stronger right now?
Data currently points to a probabilistic edge for HBAR on size and HBAR on activity. Neither reading guarantees future returns.
AI summary
PEPS synthesizes module output into a readable pair brief. Headline stats put HBAR at $0.070020 and Injective at $5.10. Relative performance over 24h (Injective) is a short window. Pair it with 30d/1y rows before inferring regime change. Return to related comparisons and individual coin intelligence pages to validate whether the relative story still holds after fresh prints.
FAQ
Which is better, HBAR or Injective?
“Better” depends on horizon and risk. HBAR leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, HBAR or INJ?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both HBAR and Injective.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. HBAR currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.